[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Amantadine HCl Oral Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

June 2024 | 127 pages | ID: GF5E1C5E103GEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Amantadine HCl Oral market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.

The Global Info Research report includes an overview of the development of the Amantadine HCl Oral industry chain, the market status of Parkinson's Disease (Tablet, Capsules), Influenza (Tablet, Capsules), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Amantadine HCl Oral.

Regionally, the report analyzes the Amantadine HCl Oral markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Amantadine HCl Oral market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Amantadine HCl Oral market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Amantadine HCl Oral industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Tablet, Capsules).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Amantadine HCl Oral market.

Regional Analysis: The report involves examining the Amantadine HCl Oral market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Amantadine HCl Oral market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Amantadine HCl Oral:

Company Analysis: Report covers individual Amantadine HCl Oral manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Amantadine HCl Oral This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Parkinson's Disease, Influenza).

Technology Analysis: Report covers specific technologies relevant to Amantadine HCl Oral. It assesses the current state, advancements, and potential future developments in Amantadine HCl Oral areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Amantadine HCl Oral market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Amantadine HCl Oral market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • Tablet
  • Capsules
  • Syrup
Market segment by Application
  • Parkinson's Disease
  • Influenza
Major players covered
  • Zydus Pharmaceuticals
  • Mylan
  • Teva
  • Vertical Pharmaceuticals
  • Adamas Pharmaceuticals
  • Upsher-Smith
  • Sandoz
  • Mikart Pharmaceuticals
  • Pharmaceutical Associates, Inc. (PAI)
  • Wockhardt Bio AG
  • CMP Pharma
  • Bionpharma
  • Graviti Pharma
  • Alembic Pharmaceuticals
  • Strides Pharma
  • Heritage Pharmaceuticals
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Amantadine HCl Oral product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Amantadine HCl Oral, with price, sales, revenue and global market share of Amantadine HCl Oral from 2019 to 2024.

Chapter 3, the Amantadine HCl Oral competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Amantadine HCl Oral breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Amantadine HCl Oral market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Amantadine HCl Oral.

Chapter 14 and 15, to describe Amantadine HCl Oral sales channel, distributors, customers, research findings and conclusion.

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Amantadine HCl Oral
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Amantadine HCl Oral Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Tablet
  1.3.3 Capsules
  1.3.4 Syrup
1.4 Market Analysis by Application
  1.4.1 Overview: Global Amantadine HCl Oral Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Parkinson's Disease
  1.4.3 Influenza
1.5 Global Amantadine HCl Oral Market Size & Forecast
  1.5.1 Global Amantadine HCl Oral Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global Amantadine HCl Oral Sales Quantity (2019-2030)
  1.5.3 Global Amantadine HCl Oral Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 Zydus Pharmaceuticals
  2.1.1 Zydus Pharmaceuticals Details
  2.1.2 Zydus Pharmaceuticals Major Business
  2.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Product and Services
  2.1.4 Zydus Pharmaceuticals Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Zydus Pharmaceuticals Recent Developments/Updates
2.2 Mylan
  2.2.1 Mylan Details
  2.2.2 Mylan Major Business
  2.2.3 Mylan Amantadine HCl Oral Product and Services
  2.2.4 Mylan Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Mylan Recent Developments/Updates
2.3 Teva
  2.3.1 Teva Details
  2.3.2 Teva Major Business
  2.3.3 Teva Amantadine HCl Oral Product and Services
  2.3.4 Teva Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Teva Recent Developments/Updates
2.4 Vertical Pharmaceuticals
  2.4.1 Vertical Pharmaceuticals Details
  2.4.2 Vertical Pharmaceuticals Major Business
  2.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Product and Services
  2.4.4 Vertical Pharmaceuticals Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Vertical Pharmaceuticals Recent Developments/Updates
2.5 Adamas Pharmaceuticals
  2.5.1 Adamas Pharmaceuticals Details
  2.5.2 Adamas Pharmaceuticals Major Business
  2.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Product and Services
  2.5.4 Adamas Pharmaceuticals Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Adamas Pharmaceuticals Recent Developments/Updates
2.6 Upsher-Smith
  2.6.1 Upsher-Smith Details
  2.6.2 Upsher-Smith Major Business
  2.6.3 Upsher-Smith Amantadine HCl Oral Product and Services
  2.6.4 Upsher-Smith Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Upsher-Smith Recent Developments/Updates
2.7 Sandoz
  2.7.1 Sandoz Details
  2.7.2 Sandoz Major Business
  2.7.3 Sandoz Amantadine HCl Oral Product and Services
  2.7.4 Sandoz Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Sandoz Recent Developments/Updates
2.8 Mikart Pharmaceuticals
  2.8.1 Mikart Pharmaceuticals Details
  2.8.2 Mikart Pharmaceuticals Major Business
  2.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Product and Services
  2.8.4 Mikart Pharmaceuticals Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Mikart Pharmaceuticals Recent Developments/Updates
2.9 Pharmaceutical Associates, Inc. (PAI)
  2.9.1 Pharmaceutical Associates, Inc. (PAI) Details
  2.9.2 Pharmaceutical Associates, Inc. (PAI) Major Business
  2.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product and Services
  2.9.4 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Developments/Updates
2.10 Wockhardt Bio AG
  2.10.1 Wockhardt Bio AG Details
  2.10.2 Wockhardt Bio AG Major Business
  2.10.3 Wockhardt Bio AG Amantadine HCl Oral Product and Services
  2.10.4 Wockhardt Bio AG Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 Wockhardt Bio AG Recent Developments/Updates
2.11 CMP Pharma
  2.11.1 CMP Pharma Details
  2.11.2 CMP Pharma Major Business
  2.11.3 CMP Pharma Amantadine HCl Oral Product and Services
  2.11.4 CMP Pharma Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 CMP Pharma Recent Developments/Updates
2.12 Bionpharma
  2.12.1 Bionpharma Details
  2.12.2 Bionpharma Major Business
  2.12.3 Bionpharma Amantadine HCl Oral Product and Services
  2.12.4 Bionpharma Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.12.5 Bionpharma Recent Developments/Updates
2.13 Graviti Pharma
  2.13.1 Graviti Pharma Details
  2.13.2 Graviti Pharma Major Business
  2.13.3 Graviti Pharma Amantadine HCl Oral Product and Services
  2.13.4 Graviti Pharma Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.13.5 Graviti Pharma Recent Developments/Updates
2.14 Alembic Pharmaceuticals
  2.14.1 Alembic Pharmaceuticals Details
  2.14.2 Alembic Pharmaceuticals Major Business
  2.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Product and Services
  2.14.4 Alembic Pharmaceuticals Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.14.5 Alembic Pharmaceuticals Recent Developments/Updates
2.15 Strides Pharma
  2.15.1 Strides Pharma Details
  2.15.2 Strides Pharma Major Business
  2.15.3 Strides Pharma Amantadine HCl Oral Product and Services
  2.15.4 Strides Pharma Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.15.5 Strides Pharma Recent Developments/Updates
2.16 Heritage Pharmaceuticals
  2.16.1 Heritage Pharmaceuticals Details
  2.16.2 Heritage Pharmaceuticals Major Business
  2.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Product and Services
  2.16.4 Heritage Pharmaceuticals Amantadine HCl Oral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.16.5 Heritage Pharmaceuticals Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: AMANTADINE HCL ORAL BY MANUFACTURER

3.1 Global Amantadine HCl Oral Sales Quantity by Manufacturer (2019-2024)
3.2 Global Amantadine HCl Oral Revenue by Manufacturer (2019-2024)
3.3 Global Amantadine HCl Oral Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of Amantadine HCl Oral by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 Amantadine HCl Oral Manufacturer Market Share in 2023
  3.4.2 Top 6 Amantadine HCl Oral Manufacturer Market Share in 2023
3.5 Amantadine HCl Oral Market: Overall Company Footprint Analysis
  3.5.1 Amantadine HCl Oral Market: Region Footprint
  3.5.2 Amantadine HCl Oral Market: Company Product Type Footprint
  3.5.3 Amantadine HCl Oral Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Amantadine HCl Oral Market Size by Region
  4.1.1 Global Amantadine HCl Oral Sales Quantity by Region (2019-2030)
  4.1.2 Global Amantadine HCl Oral Consumption Value by Region (2019-2030)
  4.1.3 Global Amantadine HCl Oral Average Price by Region (2019-2030)
4.2 North America Amantadine HCl Oral Consumption Value (2019-2030)
4.3 Europe Amantadine HCl Oral Consumption Value (2019-2030)
4.4 Asia-Pacific Amantadine HCl Oral Consumption Value (2019-2030)
4.5 South America Amantadine HCl Oral Consumption Value (2019-2030)
4.6 Middle East and Africa Amantadine HCl Oral Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global Amantadine HCl Oral Sales Quantity by Type (2019-2030)
5.2 Global Amantadine HCl Oral Consumption Value by Type (2019-2030)
5.3 Global Amantadine HCl Oral Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Amantadine HCl Oral Sales Quantity by Application (2019-2030)
6.2 Global Amantadine HCl Oral Consumption Value by Application (2019-2030)
6.3 Global Amantadine HCl Oral Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America Amantadine HCl Oral Sales Quantity by Type (2019-2030)
7.2 North America Amantadine HCl Oral Sales Quantity by Application (2019-2030)
7.3 North America Amantadine HCl Oral Market Size by Country
  7.3.1 North America Amantadine HCl Oral Sales Quantity by Country (2019-2030)
  7.3.2 North America Amantadine HCl Oral Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe Amantadine HCl Oral Sales Quantity by Type (2019-2030)
8.2 Europe Amantadine HCl Oral Sales Quantity by Application (2019-2030)
8.3 Europe Amantadine HCl Oral Market Size by Country
  8.3.1 Europe Amantadine HCl Oral Sales Quantity by Country (2019-2030)
  8.3.2 Europe Amantadine HCl Oral Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Amantadine HCl Oral Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Amantadine HCl Oral Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Amantadine HCl Oral Market Size by Region
  9.3.1 Asia-Pacific Amantadine HCl Oral Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific Amantadine HCl Oral Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America Amantadine HCl Oral Sales Quantity by Type (2019-2030)
10.2 South America Amantadine HCl Oral Sales Quantity by Application (2019-2030)
10.3 South America Amantadine HCl Oral Market Size by Country
  10.3.1 South America Amantadine HCl Oral Sales Quantity by Country (2019-2030)
  10.3.2 South America Amantadine HCl Oral Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Amantadine HCl Oral Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Amantadine HCl Oral Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Amantadine HCl Oral Market Size by Country
  11.3.1 Middle East & Africa Amantadine HCl Oral Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa Amantadine HCl Oral Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 Amantadine HCl Oral Market Drivers
12.2 Amantadine HCl Oral Market Restraints
12.3 Amantadine HCl Oral Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Amantadine HCl Oral and Key Manufacturers
13.2 Manufacturing Costs Percentage of Amantadine HCl Oral
13.3 Amantadine HCl Oral Production Process
13.4 Amantadine HCl Oral Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Amantadine HCl Oral Typical Distributors
14.3 Amantadine HCl Oral Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Amantadine HCl Oral Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Amantadine HCl Oral Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Zydus Pharmaceuticals Major Business
Table 5. Zydus Pharmaceuticals Amantadine HCl Oral Product and Services
Table 6. Zydus Pharmaceuticals Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Zydus Pharmaceuticals Recent Developments/Updates
Table 8. Mylan Basic Information, Manufacturing Base and Competitors
Table 9. Mylan Major Business
Table 10. Mylan Amantadine HCl Oral Product and Services
Table 11. Mylan Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Mylan Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva Amantadine HCl Oral Product and Services
Table 16. Teva Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Recent Developments/Updates
Table 18. Vertical Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Vertical Pharmaceuticals Major Business
Table 20. Vertical Pharmaceuticals Amantadine HCl Oral Product and Services
Table 21. Vertical Pharmaceuticals Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Vertical Pharmaceuticals Recent Developments/Updates
Table 23. Adamas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Adamas Pharmaceuticals Major Business
Table 25. Adamas Pharmaceuticals Amantadine HCl Oral Product and Services
Table 26. Adamas Pharmaceuticals Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Adamas Pharmaceuticals Recent Developments/Updates
Table 28. Upsher-Smith Basic Information, Manufacturing Base and Competitors
Table 29. Upsher-Smith Major Business
Table 30. Upsher-Smith Amantadine HCl Oral Product and Services
Table 31. Upsher-Smith Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Upsher-Smith Recent Developments/Updates
Table 33. Sandoz Basic Information, Manufacturing Base and Competitors
Table 34. Sandoz Major Business
Table 35. Sandoz Amantadine HCl Oral Product and Services
Table 36. Sandoz Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sandoz Recent Developments/Updates
Table 38. Mikart Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Mikart Pharmaceuticals Major Business
Table 40. Mikart Pharmaceuticals Amantadine HCl Oral Product and Services
Table 41. Mikart Pharmaceuticals Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Mikart Pharmaceuticals Recent Developments/Updates
Table 43. Pharmaceutical Associates, Inc. (PAI) Basic Information, Manufacturing Base and Competitors
Table 44. Pharmaceutical Associates, Inc. (PAI) Major Business
Table 45. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product and Services
Table 46. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Pharmaceutical Associates, Inc. (PAI) Recent Developments/Updates
Table 48. Wockhardt Bio AG Basic Information, Manufacturing Base and Competitors
Table 49. Wockhardt Bio AG Major Business
Table 50. Wockhardt Bio AG Amantadine HCl Oral Product and Services
Table 51. Wockhardt Bio AG Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Wockhardt Bio AG Recent Developments/Updates
Table 53. CMP Pharma Basic Information, Manufacturing Base and Competitors
Table 54. CMP Pharma Major Business
Table 55. CMP Pharma Amantadine HCl Oral Product and Services
Table 56. CMP Pharma Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. CMP Pharma Recent Developments/Updates
Table 58. Bionpharma Basic Information, Manufacturing Base and Competitors
Table 59. Bionpharma Major Business
Table 60. Bionpharma Amantadine HCl Oral Product and Services
Table 61. Bionpharma Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Bionpharma Recent Developments/Updates
Table 63. Graviti Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Graviti Pharma Major Business
Table 65. Graviti Pharma Amantadine HCl Oral Product and Services
Table 66. Graviti Pharma Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Graviti Pharma Recent Developments/Updates
Table 68. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. Alembic Pharmaceuticals Major Business
Table 70. Alembic Pharmaceuticals Amantadine HCl Oral Product and Services
Table 71. Alembic Pharmaceuticals Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Alembic Pharmaceuticals Recent Developments/Updates
Table 73. Strides Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Strides Pharma Major Business
Table 75. Strides Pharma Amantadine HCl Oral Product and Services
Table 76. Strides Pharma Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Strides Pharma Recent Developments/Updates
Table 78. Heritage Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. Heritage Pharmaceuticals Major Business
Table 80. Heritage Pharmaceuticals Amantadine HCl Oral Product and Services
Table 81. Heritage Pharmaceuticals Amantadine HCl Oral Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Heritage Pharmaceuticals Recent Developments/Updates
Table 83. Global Amantadine HCl Oral Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 84. Global Amantadine HCl Oral Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global Amantadine HCl Oral Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 86. Market Position of Manufacturers in Amantadine HCl Oral, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 87. Head Office and Amantadine HCl Oral Production Site of Key Manufacturer
Table 88. Amantadine HCl Oral Market: Company Product Type Footprint
Table 89. Amantadine HCl Oral Market: Company Product Application Footprint
Table 90. Amantadine HCl Oral New Market Entrants and Barriers to Market Entry
Table 91. Amantadine HCl Oral Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Amantadine HCl Oral Sales Quantity by Region (2019-2024) & (K Units)
Table 93. Global Amantadine HCl Oral Sales Quantity by Region (2025-2030) & (K Units)
Table 94. Global Amantadine HCl Oral Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Global Amantadine HCl Oral Consumption Value by Region (2025-2030) & (USD Million)
Table 96. Global Amantadine HCl Oral Average Price by Region (2019-2024) & (USD/Unit)
Table 97. Global Amantadine HCl Oral Average Price by Region (2025-2030) & (USD/Unit)
Table 98. Global Amantadine HCl Oral Sales Quantity by Type (2019-2024) & (K Units)
Table 99. Global Amantadine HCl Oral Sales Quantity by Type (2025-2030) & (K Units)
Table 100. Global Amantadine HCl Oral Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Global Amantadine HCl Oral Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Global Amantadine HCl Oral Average Price by Type (2019-2024) & (USD/Unit)
Table 103. Global Amantadine HCl Oral Average Price by Type (2025-2030) & (USD/Unit)
Table 104. Global Amantadine HCl Oral Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Global Amantadine HCl Oral Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Global Amantadine HCl Oral Consumption Value by Application (2019-2024) & (USD Million)
Table 107. Global Amantadine HCl Oral Consumption Value by Application (2025-2030) & (USD Million)
Table 108. Global Amantadine HCl Oral Average Price by Application (2019-2024) & (USD/Unit)
Table 109. Global Amantadine HCl Oral Average Price by Application (2025-2030) & (USD/Unit)
Table 110. North America Amantadine HCl Oral Sales Quantity by Type (2019-2024) & (K Units)
Table 111. North America Amantadine HCl Oral Sales Quantity by Type (2025-2030) & (K Units)
Table 112. North America Amantadine HCl Oral Sales Quantity by Application (2019-2024) & (K Units)
Table 113. North America Amantadine HCl Oral Sales Quantity by Application (2025-2030) & (K Units)
Table 114. North America Amantadine HCl Oral Sales Quantity by Country (2019-2024) & (K Units)
Table 115. North America Amantadine HCl Oral Sales Quantity by Country (2025-2030) & (K Units)
Table 116. North America Amantadine HCl Oral Consumption Value by Country (2019-2024) & (USD Million)
Table 117. North America Amantadine HCl Oral Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Europe Amantadine HCl Oral Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Europe Amantadine HCl Oral Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Europe Amantadine HCl Oral Sales Quantity by Application (2019-2024) & (K Units)
Table 121. Europe Amantadine HCl Oral Sales Quantity by Application (2025-2030) & (K Units)
Table 122. Europe Amantadine HCl Oral Sales Quantity by Country (2019-2024) & (K Units)
Table 123. Europe Amantadine HCl Oral Sales Quantity by Country (2025-2030) & (K Units)
Table 124. Europe Amantadine HCl Oral Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Amantadine HCl Oral Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Amantadine HCl Oral Sales Quantity by Type (2019-2024) & (K Units)
Table 127. Asia-Pacific Amantadine HCl Oral Sales Quantity by Type (2025-2030) & (K Units)
Table 128. Asia-Pacific Amantadine HCl Oral Sales Quantity by Application (2019-2024) & (K Units)
Table 129. Asia-Pacific Amantadine HCl Oral Sales Quantity by Application (2025-2030) & (K Units)
Table 130. Asia-Pacific Amantadine HCl Oral Sales Quantity by Region (2019-2024) & (K Units)
Table 131. Asia-Pacific Amantadine HCl Oral Sales Quantity by Region (2025-2030) & (K Units)
Table 132. Asia-Pacific Amantadine HCl Oral Consumption Value by Region (2019-2024) & (USD Million)
Table 133. Asia-Pacific Amantadine HCl Oral Consumption Value by Region (2025-2030) & (USD Million)
Table 134. South America Amantadine HCl Oral Sales Quantity by Type (2019-2024) & (K Units)
Table 135. South America Amantadine HCl Oral Sales Quantity by Type (2025-2030) & (K Units)
Table 136. South America Amantadine HCl Oral Sales Quantity by Application (2019-2024) & (K Units)
Table 137. South America Amantadine HCl Oral Sales Quantity by Application (2025-2030) & (K Units)
Table 138. South America Amantadine HCl Oral Sales Quantity by Country (2019-2024) & (K Units)
Table 139. South America Amantadine HCl Oral Sales Quantity by Country (2025-2030) & (K Units)
Table 140. South America Amantadine HCl Oral Consumption Value by Country (2019-2024) & (USD Million)
Table 141. South America Amantadine HCl Oral Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Middle East & Africa Amantadine HCl Oral Sales Quantity by Type (2019-2024) & (K Units)
Table 143. Middle East & Africa Amantadine HCl Oral Sales Quantity by Type (2025-2030) & (K Units)
Table 144. Middle East & Africa Amantadine HCl Oral Sales Quantity by Application (2019-2024) & (K Units)
Table 145. Middle East & Africa Amantadine HCl Oral Sales Quantity by Application (2025-2030) & (K Units)
Table 146. Middle East & Africa Amantadine HCl Oral Sales Quantity by Region (2019-2024) & (K Units)
Table 147. Middle East & Africa Amantadine HCl Oral Sales Quantity by Region (2025-2030) & (K Units)
Table 148. Middle East & Africa Amantadine HCl Oral Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Middle East & Africa Amantadine HCl Oral Consumption Value by Region (2025-2030) & (USD Million)
Table 150. Amantadine HCl Oral Raw Material
Table 151. Key Manufacturers of Amantadine HCl Oral Raw Materials
Table 152. Amantadine HCl Oral Typical Distributors
Table 153. Amantadine HCl Oral Typical Customers

LIST OF FIGURES

Figure 1. Amantadine HCl Oral Picture
Figure 2. Global Amantadine HCl Oral Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Amantadine HCl Oral Consumption Value Market Share by Type in 2023
Figure 4. Tablet Examples
Figure 5. Capsules Examples
Figure 6. Syrup Examples
Figure 7. Global Amantadine HCl Oral Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Amantadine HCl Oral Consumption Value Market Share by Application in 2023
Figure 9. Parkinson's Disease Examples
Figure 10. Influenza Examples
Figure 11. Global Amantadine HCl Oral Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Amantadine HCl Oral Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Amantadine HCl Oral Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Amantadine HCl Oral Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Amantadine HCl Oral Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Amantadine HCl Oral Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Amantadine HCl Oral by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Amantadine HCl Oral Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Amantadine HCl Oral Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Amantadine HCl Oral Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Amantadine HCl Oral Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Amantadine HCl Oral Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Amantadine HCl Oral Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Amantadine HCl Oral Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Amantadine HCl Oral Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Amantadine HCl Oral Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Amantadine HCl Oral Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Amantadine HCl Oral Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Amantadine HCl Oral Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Amantadine HCl Oral Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Amantadine HCl Oral Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Amantadine HCl Oral Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Amantadine HCl Oral Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Amantadine HCl Oral Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Amantadine HCl Oral Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Amantadine HCl Oral Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Amantadine HCl Oral Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Amantadine HCl Oral Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Amantadine HCl Oral Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Amantadine HCl Oral Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Amantadine HCl Oral Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Amantadine HCl Oral Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Amantadine HCl Oral Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Amantadine HCl Oral Consumption Value Market Share by Region (2019-2030)
Figure 53. China Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Amantadine HCl Oral Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Amantadine HCl Oral Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Amantadine HCl Oral Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Amantadine HCl Oral Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Amantadine HCl Oral Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Amantadine HCl Oral Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Amantadine HCl Oral Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Amantadine HCl Oral Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Amantadine HCl Oral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Amantadine HCl Oral Market Drivers
Figure 74. Amantadine HCl Oral Market Restraints
Figure 75. Amantadine HCl Oral Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Amantadine HCl Oral in 2023
Figure 78. Manufacturing Process Analysis of Amantadine HCl Oral
Figure 79. Amantadine HCl Oral Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications